The impact of low-fat diets on the plasma lipoprotein profile is incompletely understood.
Methods
We conducted two 16-week dietary studies to compare the effects of a moderate-fat (mod-FAT) baseline diet with isocaloric and ad libitum low-fat diets rich in either carbohydrates (high-CHO, n = 16) or protein (high-PRO, n = 19) on plasma lipids, post-heparin lipase activities, cholesteryl ester transfer protein, and phospholipid transfer protein.
Results
Switching from the mod-FAT to the isocaloric high-CHO diet lowered plasma high-density lipoprotein cholesterol concentrations (P < 0.001) and tended to increase triglyceride levels (P = 0.087). Cholesterol content in the larger, buoyant low-density lipoprotein (LDL) fractions decreased, whereas those of the very-low-density lipoprotein, intermediate-density lipoprotein, and smaller, denser LDL fractions tended to increase. These changes were largely reversed when subjects lost weight by consuming this high-CHO diet ad libitum. Switching from the mod-FAT diet to the isocaloric high-PRO diet did not increase cholesterol content in the small-dense LDL fraction and led to decreases in both LDL and high-density lipoprotein cholesterol in plasma (P < 0.001 for both).
Consumption of the high-protein ad libitum diet accompanied by weight loss did not change plasma lipids further, except for a shift of cholesterol from dense low-density lipoprotein fractions to more buoyant low-density lipoprotein fractions. Cholesteryl ester transfer protein concentrations decreased with high-cholesterol feeding, whereas cholesteryl ester transfer protein concentrations and hepatic lipase and phospholipid transfer protein activities all decreased during high-protein feeding.
Conclusions
Both high-CHO and high-PRO diets improve plasma lipid-related risk of cardiovascular disease when consumed ad libitum.
SinghIM, ShishehborMH, AnsellBJ. High-density lipoprotein as a therapeutic target: a systematic review. JAMA. 2007;298:786–798.
3.
LaRosaJC. Low-density lipoprotein cholesterol reduction: the end is more important than the means. Am J Cardiol. 2007;100:240–242.
4.
RizzoM, BerneisK. Should we measure routinely the LDL peak particle size?Int J Cardiol. 2006;107:166–170.
5.
MorganJ, CareyC, LincoffA. High-density lipoprotein subfractions and risk of coronary artery disease. Curr Atheroscler Rep. 2004;6:359–365.
6.
BarterPJ, BrewerHBJr, ChapmanMJ, . Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23:160–167.
7.
SchlittA, BickelC, ThummaP, . High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol. 2003;23:1857–1862.
8.
EbenbichlerCF, LaimerM, KaserS, . Relationship between cholesteryl ester transfer protein and atherogenic lipoprotein profile in morbidly obese women. Arterioscler Thromb Vasc Biol. 2002;22:1465–1469.
9.
TzotzasT, DumontL, TriantosA, . Early decreases in plasma lipid transfer proteins during weight reduction. Obesity (Silver Spring). 2006;14:1038–1045.
10.
MurdochSJ, KahnSE, AlbersJJ, . PLTP activity decreases with weight loss: changes in PLTP are associated with changes in subcutaneous fat and FFA but not IAF or insulin sensitivity. J Lipid Res. 2003;44:1705–1712.
11.
LichtensteinAH. Thematic review series: patient-oriented research. Dietary fat, carbohydrate, and protein: effects on plasma lipoprotein patterns. J Lipid Res. 2006;47:1661–1667.
12.
KraussRM. Dietary and genetic effects on low-density lipoprotein heterogeneity. Annu Rev Nutr. 2001;21:283–295.
13.
SacksFM, KatanM. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med. 2002;113(suppl 9B):13S-24S.
14.
AstrupA, GrunwaldGK, MelansonEL, . The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies. Int J Obes Relat Metab Disord. 2000;24:1545–1552.
15.
KratzM, CullenP, WahrburgU. The impact of dietary mono- and polyunsaturated fatty acids on risk factors for atherosclerosis in humans. Eur J Lipid Sci Technol. 2002;104:300–311.
16.
ParksEJ. Effect of dietary carbohydrate on triglyceride metabolism in humans. J Nutr. 2001;131:2772S–2774S.
17.
WeigleDS, BreenPA, MatthysCC, . A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations. Am J Clin Nutr. 2005;82:41–48.
18.
WeigleDS, CummingsDE, NewbyPD, . Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. J Clin Endocrinol Metab. 2003;88:1577–1586.
19.
UllmannD, ConnorWE, HatcherLF, . Will a high-carbohydrate, low-fat diet lower plasma lipids and lipoproteins without producing hypertriglyceridemia?Arterioscler Thromb. 1991;11:1059–1067.
KendallA, LevitskyDA, StruppBJ, . Weight loss on a low-fat diet: consequence of the imprecision of the control of food intake in humans. Am J Clin Nutr. 1991;53:1124–1129.
22.
BrownG, AlbersJJ, FisherLD, . Regression of coronary artery disease as a result of intensive lipid- lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990;323:1289–1298.
23.
CapellWH, ZambonA, AustinMA, . Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B. Arterioscler Thromb Vasc Biol. 1996;16:1040–1046.
24.
IveriusPH, BrunzellJD. Human adipose tissue lipoprotein lipase: changes with feeding and relation to postheparin plasma enzyme. Am J Physiol. 1985;249:E107–E114.
25.
CarrMC, AyyobiAF, MurdochSJ, . Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women. Arterioscler Thromb Vasc Biol. 2002;22:667–673.
26.
MurdochSJ, CarrMC, HokansonJE, . PLTP activity in premenopausal women. Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance. J Lipid Res. 2000;41:237–244.
27.
CheungMC, WolfbauerG, AlbersJJ. Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters. Biochim Biophys Acta. 1996;1303:103–110.
28.
AuwerxJH, MarzettaCA, HokansonJE, . Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis. 1989;9:319–325.
29.
SchaeferEJ, LichtensteinAH, Lamon-FavaS, . Body weight and low-density lipoprotein cholesterol changes after consumption of a low-fat ad libitum diet. JAMA. 1995;274:1450–1455.
30.
Kasim-KarakasSE, AlmarioRU, MuellerWM, . Changes in plasma lipoproteins during low-fat, high-carbohydrate diets: effects of energy intake. Am J Clin Nutr. 2000;71:1439–1447.
31.
KraussRM, BlanchePJ, RawlingsRS, . Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am J Clin Nutr. 2006;83:1025–1031; quiz 1205.
32.
MensinkRP, ZockPL, KesterAD, . Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77:1146–1155.
33.
AkopianD, MedhJD. Genetics and molecular biology: phospholipid transfer protein in atherogenesis. Curr Opin Lipidol. 2006;17:695–698.
34.
SchaeferEJ, AsztalosBF. Cholesteryl ester transfer protein inhibition, high-density lipoprotein metabolism and heart disease risk reduction. Curr Opin Lipidol. 2006;17:394–398.
35.
MurdochSJ, CarrMC, KennedyH, . Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution. J Lipid Res. 2002;43:1256–1263.
36.
KaserS, LaimerM, SandhoferA, . Effects of weight loss on PLTP activity and HDL particle size. Int J Obes Relat Metab Disord. 2004;28:1280–1282.
37.
TallAR. Plasma cholesteryl ester transfer protein. J Lipid Res. 1993;34:1255–1274.
38.
JansenS, Lopez-MirandaJ, CastroP, . Low-fat and high-monounsaturated fatty acid diets decrease plasma cholesterol ester transfer protein concentrations in young, healthy, normolipemic men. Am J Clin Nutr. 2000;72:36–41.
39.
SteinY, SteinO. Lipoprotein lipase and atherosclerosis. Atherosclerosis. 2003;170:1–9.9.
CamposH, RoedererGO, Lussier-CacanS, . Predominance of large LDL and reduced HDL2 cholesterol in normolipidemic men with coronary artery disease. Arterioscler Thromb Vasc Biol. 1995;15:1043–1048.
42.
PiekeB, vonEckardstein A, GulbahceE, . Treatment of hypertriglyceridemia by two diets rich either in unsaturated fatty acids or in carbohydrates: effects on lipoprotein subclasses, lipolytic enzymes, lipid transfer proteins, insulin and leptin. Int J Obes Relat Metab Disord. 2000;24:1286–1296.
43.
PurnellJQ, KahnSE, AlbersJJ, . Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J Clin Endocrinol Metab. 2000;85:977–982.
44.
SchaeferEJ, GleasonJA, DansingerML. Dietary fructose and glucose differentially affect lipid and glucose homeostasis. J Nutr. 2009;139:1257S–1262S.
45.
StanhopeKL, SchwarzJM, KeimNL, . Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119:1322–1334.
46.
AdielsM, TaskinenMR, PackardC, . Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 2006;49:755–765.
